Evidence map›Paper›PMID 40638546›Full record

ArticleJournal of cellular and molecular medicine2025

Fibronectin 1 Aggravates Colon Cancer Metastasis by Regulating RAP1B Protein Stability Through Akt/CREB Signalling Pathway.

Zhonghe Ji, Xinbao Li, Yadong Wang, Xinjing Zhang, Zhiran Yang, Yanbin Zhang, Junhui Yu, Chao Gao, Guojun Yan, Lijun Yan and 3 more

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zhonghe JiDepartment of Peritoneal Oncology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Xinbao LiDepartment of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Yadong WangScientific Research Department, GeneX Health Co. Ltd., Beijing, China.
Xinjing ZhangDepartment of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Zhiran YangDepartment of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Yanbin ZhangDepartment of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Junhui YuDepartment of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Chao GaoDepartment of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Guojun YanDepartment of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Lijun YanDepartment of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Kai ZhangDepartment of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Jinghan PanDepartment of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Songlin AnDepartment of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.ORCID 0009-0001-3549-4448

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastasis is one of the important factors leading to poor prognosis in patients with colon cancer. However, the molecular mechanism contributing to this cellular behaviour remains largely unknown. Here, RNA-seq analysis suggested that Fibronectin 1 (FN1) was significantly increased in metastatic colon cancer, which was associated with poor prognosis. FN1 enhanced colon cancer cell migration, invasion, and epithelial to mesenchymal transition (EMT) in vitro and promoted liver and lung metastasis of colon cancer in nude mice through RAP1B. Mechanistically, FN1 could interact with RAP1B by suppressing the interaction between RAP1B and the E3 ligase PARK2, relieving RAP1B ubiquitination modification and improving RAP1B protein stability. Furthermore, FN1-RAP1B activated Akt signalling pathway, leading to the phosphorylation and activation of CREB. Interestingly, CREB was found directly bound to the FN1 and TIMP1 promoter, respectively and increased FN1 and TIMP1 transcription, thereby establishing a positive regulatory feedback loop. Overall, our results elucidated that FN1 promotes colon cancer migration, invasion, and metastasis. FN1 may be used as the potential therapeutic target for colon cancer metastasis.

Indexed as

Colonic NeoplasmsCyclic AMP Response Element-Binding ProteinFibronectinsProto-Oncogene Proteins c-aktrap GTP-Binding ProteinsSignal TransductionAnimalsCell Line, TumorCell MovementEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHumansMaleMiceMice, Inbred BALB CMice, NudeCREB1 protein, humanCyclic AMP Response Element-Binding ProteinFibronectinsFN1 protein, humanProto-Oncogene Proteins c-aktRAP1B protein, humanrap GTP-Binding ProteinsAkt/CREB signallingcolon cancerfibronectin 1metastasis

Identifiers

PMID40638546
PMCPMC12244390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.